Brought to you by CancerNetwork

Leaderboard

  • Round 3 (Active)

    Do you know in which patients it can be appropriate to omit post-lumpectomy radiotherapy? How about the standard treatment duration for trastuzumab in HER2-positive breast cancer patients? Find out the answers in Round 3!

  • Round 1 (Closed)

    In our opening round we check your knowledge of breast cancer screening guidelines, test your management strategies in ductal carcinoma in situ, and present a pair of challenging cases to see if your diagnostic skills are worthy of a champion.

  • Round 2 (Closed)

    In this round we continue with another series of puzzlers. Are you up to date on clinical risk factors in premenopausal and postmenopausal breast cancer? And what is the estimated incidence of breast cancer in men this year?

Join the CancerNetwork community